Sensorium Therapeutics

Developer of therapeutics for psychiatric and neurological disorders

placeBoston, Massachusetts, United States calendar_todayFounded 2021 groups23 employees language sensorium.bio

Social engagement

Social engagement: 4.4K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Sante, Route 66 Ventures, CU Healthcare Innovation Fund.

Investor typeCountShare
Venture capital880%
Private equity110%
Other / undisclosed110%

Recent activity

19 Jun 2026
Event
BIO2026
28 May 2026
Event
brAIn Hub Summit
Coming soon